Kubicek GJ - Search Results

1

Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.

Kubicek GJ, Axelrod RS, Machtay M, Ahn PH, Anne PR, Fogh S, Cognetti D, Myers TJ, Curran WJ Jr, Dicker AP. Kubicek GJ, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1192-7. doi: 10.1016/j.ijrobp.2011.09.023. Epub 2012 Jan 13. Int J Radiat Oncol Biol Phys. 2012. PMID: 22245208 Clinical Trial.

2

New advances in high-technology radiotherapy for head and neck cancer.

Kubicek GJ, Machtay M. Kubicek GJ, et al. Hematol Oncol Clin North Am. 2008 Dec;22(6):1165-80, viii. doi: 10.1016/j.hoc.2008.08.014. Hematol Oncol Clin North Am. 2008. PMID: 19010266 Review.

3

Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.

Kubicek GJ, Werner-Wasik M, Machtay M, Mallon G, Myers T, Ramirez M, Andrews D, Curran WJ Jr, Dicker AP. Kubicek GJ, et al. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):433-9. doi: 10.1016/j.ijrobp.2008.08.050. Epub 2008 Dec 10. Int J Radiat Oncol Biol Phys. 2009. PMID: 19084346 Free PMC article. Clinical Trial.

4

Time of decline in sexual function after external beam radiotherapy for prostate cancer.

Siglin J, Kubicek GJ, Leiby B, Valicenti RK. Siglin J, et al. Among authors: kubicek gj. Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):31-5. doi: 10.1016/j.ijrobp.2009.01.070. Int J Radiat Oncol Biol Phys. 2010. PMID: 19395191

5

Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study.

Den RB, Doemer A, Kubicek G, Bednarz G, Galvin JM, Keane WM, Xiao Y, Machtay M. Den RB, et al. Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1353-9. doi: 10.1016/j.ijrobp.2009.03.059. Epub 2009 Jun 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 19540071

6

Importance of treatment institution in head and neck cancer radiotherapy.

Kubicek GJ, Wang F, Reddy E, Shnayder Y, Cabrera CE, Girod DA. Kubicek GJ, et al. Otolaryngol Head Neck Surg. 2009 Aug;141(2):172-6. doi: 10.1016/j.otohns.2009.03.019. Otolaryngol Head Neck Surg. 2009. PMID: 19643247

7

PSA decrease during combined-modality radiotherapy predicts for treatment outcome.

Kubicek GJ, Naguib M, Redfield S, Grayback N, Olszanski A, Dawson G, Brown SI. Kubicek GJ, et al. Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):759-62. doi: 10.1016/j.ijrobp.2009.08.064. Epub 2010 Feb 18. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171805

8

FDG-PET staging and importance of lymph node SUV in head and neck cancer.

Kubicek GJ, Champ C, Fogh S, Wang F, Reddy E, Intenzo C, Dusing RW, Machtay M. Kubicek GJ, et al. Head Neck Oncol. 2010 Jul 16;2:19. doi: 10.1186/1758-3284-2-19. Head Neck Oncol. 2010. PMID: 20637102 Free PMC article.

9

Chemotherapy in head and neck cancer: clinical predictors of tolerance and outcomes.

Kubicek GJ, Kimler BF, Wang F, Reddy EK, Girod DA, Williamson SK. Kubicek GJ, et al. Am J Clin Oncol. 2011 Aug;34(4):380-4. doi: 10.1097/COC.0b013e3181e9c0a2. Am J Clin Oncol. 2011. PMID: 20881477

10

Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?

Fogh SE, Yu A, Kubicek GJ, Scott W, Mitchell E, Rosato EL, Berger AC. Fogh SE, et al. Among authors: kubicek gj. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1372-6. doi: 10.1016/j.ijrobp.2010.04.055. Epub 2010 Nov 23. Int J Radiat Oncol Biol Phys. 2011. PMID: 21106309

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters